Skip to content
About
Close About
Open About
About ScreenCell
Who are we ?
Events
News
Press releases
Technology
Clinical Trials
Resources
Close Resources
Open Resources
Scientific resources
Publications
Posters
Videos
Blog
Contact
Quote
FR
Home
>
Scientific articles
>
Prostate cancer
Prostate cancer
Prostate cancer
Strategies for Isolating and Propagating Circulating Tumor Cells in Men with Metastatic Prostate Cancer
15 February 2022
Read the publication
Prostate cancer
Circulating Tumour Cell Numbers Correlate with Platelet Count and Circulating Lymphocyte Subsets in Men with Advanced Prostate Cancer: Data from the ExPeCT Clinical Trial (CTRIAL-IE 15-21).
18 September 2021
Read the publication
Prostate cancer
Validation of Cell-Free RNA and Circulating Tumor Cells for Molecular Marker Analysis in Metastatic Prostate Cancer
12 August 2021
Read the publication
Prostate cancer
Development and validation of circulating tumour cell enumeration (Epic Sciences) as a prognostic biomarker in men with metastatic castration-resistant prostate cancer
21 April 2021
Read the publication
Prostate cancer
Prospective Multicenter Study of Circulating Tumor Cell AR-V7 and Taxane Versus Hormonal Treatment Outcomes in Metastatic Castration-Resistant Prostate Cancer
28 October 2020
Read the publication
Prostate cancer
Genomic Analysis of Localized High-Risk Prostate Cancer Circulating Tumor Cells at the Single-Cell Level
8 August 2020
Read the publication
Prostate cancer
Platinum-Based Chemotherapy in Metastatic Prostate Cancer With DNA Repair Gene Alterations
16 April 2020
Read the publication
Prostate cancer
Long-Term Dynamics of Three Dimensional Telomere Profiles in Circulating Tumor Cells in High-Risk Prostate Cancer Patients Undergoing Androgen-Deprivation and Radiation Therapy
14 August 2019
Read the publication
Prostate cancer
Advancing Risk Assessment of Intermediate Risk Prostate Cancer Patients
20 June 2019
Read the publication
Prostate cancer
Filtration-based enrichment of circulating tumor cells from all prostate cancer risk groups
12 February 2017
Read the publication